Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy

By sjmartinez • February 22, 2024

Nevarez-Mejia J, Jin YP, Pickering H, Parmar R, Valenzuela NM, Sosa RA, Heidt S, Fishbein GA, Rozengurt E, Baldwin WM 3rd, Fairchild RL, Reed EF. Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy. Am J Transplant. 2023 Oct 29:S1600-6135(23)00822-5. doi: 10.1016/j.ajt.2023.10.020. Epub ahead of print. PMID: 38379280.

Tags: AMR, antibody-mediated rejection, AOIs, areas of interest, cardiac allograft vasculopathy, CAV, Digestive Diseases, donor-specific HLA antibodies, DSA, EC, endothelial cell, HLA, human leukocyte antigen, Publications, transplant vasculopathy, TV

Profiles of nonsteroidal anti-inflammatory drug-induced gastric antral ulcers: A comprehensive review of the preclinical data

Satoh H, Akiba Y, Kaunitz JD. Profiles of nonsteroidal anti-inflammatory drug-induced gastric antral ulcers: A comprehensive review of the preclinical data. J Pharmacol Exp Ther.[...]

The Society of Thoracic Surgeons (2026) Expert Consensus Document on Management of Esophageal Perforation

Worrell S, Antonoff MB, Kent MS, Kolb JM, Liou DZ, Louie BE, Rice JD, Schulman AR, Sood P, Sridhar P, Velotta JB, Hayanga JWA. The[...]

Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome

Ou Y, Lim A, Wang R, Mir N, Calsavara VF, Wang Q, Zhang Y, Pandol SJ, Edderkaoui M. Specific targeting of cancer cell mitochondria with[...]